Gofen & Glossberg’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.75M | Sell |
3,409
-223
| -6% | -$113K | 0.05% | 202 |
|
|
2022
Q3 | $1.65M | Buy |
3,632
+1,106
| +44% | +$529K | 0.05% | 200 |
|
|
2022
Q2 | $1.22M | Buy |
2,526
+180
| +8% | +$89K | 0.03% | 221 |
|
|
2022
Q1 | $1.15M | Sell |
2,346
-4
| -0.2% | -$1.83K | 0.03% | 234 |
|
|
2021
Q4 | $1.09M | Hold |
2,350
| – | – | 0.02% | 237 |
|
|
2021
Q3 | $876K | Buy |
2,350
+38
| +2% | +$14.4K | 0.02% | 254 |
|
|
2021
Q2 | $883K | Buy |
2,312
+50
| +2% | +$19.1K | 0.02% | 253 |
|
|
2021
Q1 | $812K | Sell |
2,262
-56
| -2% | -$18K | 0.02% | 259 |
|
|
2020
Q4 | $744K | Buy |
2,318
+23
| +1% | +$7.06K | 0.02% | 263 |
|
|
2020
Q3 | $616K | Hold |
2,295
| – | – | 0.02% | 267 |
|
|
2020
Q2 | $604K | Buy |
2,295
+17
| +0.7% | +$4.54K | 0.02% | 257 |
|
|
2020
Q1 | $517K | Hold |
2,278
| – | – | 0.02% | 262 |
|
|
2019
Q4 | $688K | Buy |
2,278
+203
| +10% | +$55.9K | 0.02% | 256 |
|
|
2019
Q3 | $498K | Sell |
2,075
-135
| -6% | -$37K | 0.02% | 291 |
|
|
2019
Q2 | $624K | Hold |
2,210
| – | – | 0.02% | 259 |
|
|
2019
Q1 | $634K | Sell |
2,210
-55
| -2% | -$15.9K | 0.02% | 243 |
|
|
2018
Q4 | $595K | Hold |
2,265
| – | – | 0.02% | 241 |
|
|
2018
Q3 | $621K | Hold |
2,265
| – | – | 0.02% | 256 |
|
|
2018
Q2 | $539K | Sell |
2,265
-50
| -2% | -$11.6K | 0.02% | 269 |
|
|
2018
Q1 | $509K | Sell |
2,315
-50
| -2% | -$11.7K | 0.02% | 275 |
|
|
2017
Q4 | $532K | Sell |
2,365
-10
| -0.4% | -$2.13K | 0.02% | 284 |
|
|
2017
Q3 | $451K | Sell |
2,375
-165
| -6% | -$31.4K | 0.02% | 309 |
|
|
2017
Q2 | $478K | Buy |
2,540
+15
| +0.6% | +$2.69K | 0.02% | 294 |
|
|
2017
Q1 | $418K | Sell |
2,525
-308
| -11% | -$49K | 0.02% | 316 |
|
|
2016
Q4 | $407K | Sell |
2,833
-150
| -5% | -$20.1K | 0.02% | 303 |
|
|
2016
Q3 | $374K | Sell |
2,983
-11
| -0.4% | -$1.42K | 0.02% | 313 |
|
|
2016
Q2 | $393K | Sell |
2,994
-219
| -7% | -$30K | 0.02% | 300 |
|
|
2016
Q1 | $447K | Buy |
3,213
+23
| +0.7% | +$3.07K | 0.02% | 289 |
|
|
2015
Q4 | $445K | Hold |
3,190
| – | – | 0.02% | 288 |
|
|
2015
Q3 | $447K | Buy |
3,190
+300
| +10% | +$45.1K | 0.02% | 283 |
|
|
2015
Q2 | $474K | Hold |
2,890
| – | – | 0.02% | 282 |
|
|
2015
Q1 | $446K | Buy |
2,890
+1,225
| +74% | +$174K | 0.02% | 289 |
|
|
2014
Q4 | $209K | Buy |
+1,665
| New | +$206K | 0.01% | 426 |
|
Other funds holding ELV
Gofen & Glossberg's ELV Position: Q4 2022 in Review
Gofen & Glossberg reduced its Elevance Health (ELV) stake by 6.1% in Q4 2022, selling an estimated $113K and leaving 3,409 shares worth $1.75M. The position accounts for 0.05% of the portfolio, ranked #202.
Gofen & Glossberg first reported a position in ELV in Q4 2014 and has held it in 33 quarters since. 1,549 funds tracked by Wall St. Rank hold ELV as of Q4 2022.
- Gofen & Glossberg held 3,409 shares of Elevance Health worth $1.75M as of Q4 2022.
- Gofen & Glossberg sold 223 Elevance Health shares in Q4 2022, an estimated $113K.
- Elevance Health made up 0.05% of Gofen & Glossberg's portfolio in Q4 2022, its #202 holding.
- Gofen & Glossberg first reported a position in Elevance Health in Q4 2014 and has held it in 33 quarters since.
- 1,549 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.